Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
  1. 4 Open-market sale Executive VP, Drug Development sold 494 shares at $30.62 ($15,125)
  2. 4 Open-market sale Executive VP, Drug Development sold 6,000 shares at $32.07 ($192,433)
  3. 4 Exercise or conversion Chief Executive Officer acquired 19,675 shares (option exercise)
  4. 4 Open-market sale Director sold 2,695,000 shares at $35.75 ($96,346,250)
  5. 4 Open-market sale Executive VP, Drug Development sold 6,000 shares at an average $37.53 ($225,179)
  6. 4 Open-market sale CFO & SVP, Finance sold 30,000 shares at an average $38.17 ($1,145,230)
  7. 4 Open-market sale President sold 225,000 shares at an average $38.98 ($8,769,818)
  8. 4 Open-market sale Chief Executive Officer sold 50,000 shares at $39.05 ($1,952,500)
  9. 4 Open-market buy Director bought 192,308 shares at $26.00 ($5,000,008)
  10. 4 Open-market sale Executive VP, Drug Development sold 18,000 shares at $30.00 ($540,000)
  11. 4 Open-market sale Chief Executive Officer sold 100,000 shares at $29.75 ($2,975,000)
  12. 4 Open-market sale Chief Executive Officer sold 100,000 shares at $24.75 ($2,475,000)
  13. 4 Open-market sale Executive VP, Drug Development sold 7,584 shares at $20.00 ($151,680)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Other acquisition Chief Executive Officer acquired 1,684 shares (other)
  20. 4 Derivatives Options or other derivatives

Page 14 of 30 · 585 filings